EMAIL DETAILS

Eric D. Schwerin
eschwerin@rosemontseneca.com

Sent from my iPhone

Begin forwarded message:

*From:* Dennis Toner <dennistoner@gmail.com>
*Date:* February 5, 2015 at 8:56:37 PM EST
*To:* Schwerin Eric <eschwerin@rosemontseneca.com>
*Subject:* *Fwd: Toner checking in*

Eric, assume you know Imprimis is working with the Boies firm. Will call u
tomorrow. Best, Dennis.

Dennis Toner
Horizon Advisors
302-547-1110


Begin forwarded message:

*From:* Mark Baum <mark@imprimispharma.com>
*Date:* February 5, 2015 at 8:09:28 PM EST
*To:* Dennis Toner <dennistoner@gmail.com>
*Subject:* *RE: Toner checking in*

Dennis:

Thanks for checking in. I hope you are staying warm on the east coast!

Following your introduction, we engaged and are working with Lisa Barclay
who joined Boies. Unfortunately, Lisa has little pull on the payment side
of things. This will require lobbying and getting in front of policy
makers. I must tell you that ONE GUY at CMS recently submitted a policy
transmittal -- one guy -- and it basically ensured that Medicare patients
would have limited access to choosing Dropless Cataract Surgery. In fact,
he basically ensured that only rich people would have access. He also
ensured that Medicare would continue to incur an additional $1B in costs
related to cataract surgery drugs (i.e. paying for the expensive drops).
It simply blows my mind that one bureaocrat in government can make a
decision like this and make 80 year old cataract patients put eye drops in
their eyes 300 times after surgery ... etc. I keep hearing that Medicare
is looking for ways to save money -- and this seems like a no brainer. It
also seems like a great way to endear oneself to lots of Medicare age
voters. But who knows?!

We are going to keep fighting, but I wish I had access to someone who could
give us a fair shot at making this option available to people with physical
disabilities, poorer Medicare patients and others.

If you have any ideas, I would be sincerely grateful.


Best Regards,

Mark L. Baum
Executive Director, C.E.O.
12264 El Camino Real, Suite 350
San Diego, CA 92130
O: 858.704.4044
M: 858.405.4448
E : mark@imprimispharma.com
NASDAQ: IMMY | Website | LinkedIn


Email Disclaimer: This email and any files transmitted with it are
confidential and intended solely for the use of the individual or entity to
whom they are addressed. If you have received this email in error please
notify the system manager. This message contains confidential information
and is intended only for the individual named. If you are not the named
addressee you should not disseminate, distribute or copy this e-mail.
Please notify the sender immediately by e-mail if you have received this
e-mail by mistake and delete this e-mail from your system. If you are not
the intended recipient you are notified that disclosing, copying,
distributing or taking any action in reliance on the contents of this
information is strictly prohibited.

-----Original Message-----
From: Dennis Toner [mailto:dennistoner@gmail.com <dennistoner@gmail.com>]
Sent: Thursday, February 05, 2015 3:33 PM
To: Mark Baum
Subject: Toner checking in

Mark, just wish to make sure Imprimis is on a good course as it relates to
DC. I've had a few calls relating to earlier meetings and your
status...assume you are making progress? Best, Dennis.


Dennis Toner
Horizon Advisors
302-547-111